Related articles

• Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing
  2024, 38(4): 358-368. DOI: 10.7555/JBR.38.20240030
• Genetic variants in C1GALT1 are associated with gastric cancer risk by influencing immune infiltration
  2024, 38(4): 348-357. DOI: 10.7555/JBR.37.20230161
• Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated FAM227A expression
  2024, 38(2): 149-162. DOI: 10.7555/JBR.37.20230049
• Alternative polyadenylation-related genetic variants contribute to bladder cancer risk
  2023, 37(6): 405-417. DOI: 10.7555/JBR.37.20230063
• Genetic variants in the Hedgehog signaling pathway genes are associated with gastric cancer risk in a Chinese Han population
  2022, 36(1): 22-31. DOI: 10.7555/JBR.35.20210091
• Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
  2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
• Non-alcoholic fatty liver disease: a narrative review of genetics
  2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
• Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea
  2018, 32(4): 257-263. DOI: 10.7555/JBR.32.20170089
• Genetic variants at 10q23.33 are associated with plasma lipid levels in a Chinese population
  2014, 28(1): 53-58. DOI: 10.7555/JBR.27.20120091
• A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population
  2012, 26(5): 315-318. DOI: 10.7555/JBR.26.20110087